Dexamethasone, cyclophosphamide, idarubicin and etoposide (DC-IE): a novel, intensive induction chemotherapy regimen for patients with high-risk multiple myeloma.

Autor: BALLESTER, O. F., MOSCINSKI, L. C., FIELDS, K. K., HIEMENZ, J. W., ZORSKY, P. E., GOLDSTEIN, S. C., SABA, H. I., SPIERS, A. S. D., KRONISH, L., SULLIVAN, P., ELFENBEIN, G. J.
Zdroj: British Journal of Haematology; Mar1997, Vol. 96 Issue 4, p746-748, 3p
Databáze: Complementary Index
Externí odkaz: